stars 1 stars 2 stars 3

HEXACATH is a medical device company leader in Bio Active coronary Stent to treat Acute Coronary Syndromes.

Hexacath Questions

The Hexacath annual revenue was $21.4 million in 2026.

Anthony Brandy is the Directeur R and D et Industrialisation of Hexacath.

17 people are employed at Hexacath.

Hexacath is based in Rueil-Malmaison, Wallis and Futuna.

The NAICS codes for Hexacath are [339, 33].

The SIC codes for Hexacath are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users